Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 9, 2016
August 02 2016 - 4:05PM
Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company
focused on the discovery, development and commercialization of
recombinant nanoparticle vaccines and adjuvants, today announced it
will report its second quarter 2016 financial and operating results
after the close of U.S. financial markets on Tuesday, August 9,
2016.
Management will host a conference call to
discuss the quarterly financial results and provide an update on
corporate activities.
Conference call details are as follows:
| Date: |
|
Tuesday, August 9, 2016 |
| Time: |
|
4:30 p.m. U.S. Eastern Time (ET) |
| Dial-in number: |
|
(877) 212-6076 (Domestic) or (707) 287-9331
(International) |
| Passcode: |
|
59901631 |
| Via web: |
|
www.novavax.com, “Investors”/ “Events” |
| |
|
|
Conference call replay:
| Date: |
|
Starting at 7:30 p.m. ET, August 9, 2016 until
August 16, 2016 |
| Dial-in number: |
|
(855) 859-2056 (Domestic) or (404) 537-3406
(International) |
| Passcode: |
|
59901631 |
| Via web: |
|
www.novavax.com, “Investors”/ “Events” |
| |
|
|
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
vaccine company committed to delivering novel products to prevent a
broad range of infectious diseases. Its recombinant nanoparticles
and Matrix-M™ adjuvant technology are the foundation for
groundbreaking innovation that improves global health through safe
and effective vaccines.
Contact:
Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir@novavax.com
240-268-2000
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024
